Nixon Peabody Trust’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4M Sell
102,145
-3,245
-3% -$643K 1.51% 17
2026
Q1
$17.3M Sell
105,390
-6,318
-6% -$1.09M 1.38% 18
2025
Q4
$19.8M Sell
111,708
-5,322
-5% -$888K 1.5% 17
2025
Q3
$18.6M Buy
117,030
+31
+0% +$4.58K 1.36% 20
2025
Q2
$16.5M Sell
116,999
-687
-0.6% -$84.4K 1.28% 22
2025
Q1
$13.7M Sell
117,686
-198
-0.2% -$25.5K 1.17% 31
2024
Q4
$14.8M Buy
117,884
+2,200
+2% +$271K 1.22% 28
2024
Q3
$12.1M Buy
115,684
+768
+0.7% +$77.3K 1% 37
2024
Q2
$11.2M Sell
114,916
-1,049
-0.9% -$99.9K 0.99% 39
2024
Q1
$10.9M Buy
115,965
+6,102
+6% +$537K 1% 45
2023
Q4
$10.2M Buy
+109,863
New +$8.79M 1.15% 38

Other funds holding MS

Nixon Peabody Trust's MS Position: Q2 2026 in Review

Nixon Peabody Trust reduced its Morgan Stanley (MS) stake by 3.1% in Q2 2026, selling an estimated $643K and leaving 102,145 shares worth $21.4M. The position accounts for 1.51% of the portfolio, ranked #17.

Nixon Peabody Trust first reported a position in MS in Q4 2023 and has held it in 11 quarters since. 1,021 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Nixon Peabody Trust held 102,145 shares of Morgan Stanley worth $21.4M as of Q2 2026.
  • Nixon Peabody Trust sold 3,245 Morgan Stanley shares in Q2 2026, an estimated $643K.
  • Morgan Stanley made up 1.51% of Nixon Peabody Trust's portfolio in Q2 2026, its #17 holding.
  • Nixon Peabody Trust first reported a position in Morgan Stanley in Q4 2023 and has held it in 11 quarters since.
  • 1,021 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.